Lupin, Mylan to commercialize Enbrel Biosimilar
Under the terms of the agreement, Lupin will receive an up-front payment of $15 million.
Pharma major Lupin Limited and global pharmaceutical company Mylan have a...
Mastering ADC Bioconjugation: From DAR Control to Efficient Free Payload Removal
Continue readingAdvertisement
Advertisement
Advertisement
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.